看板Gossiping
備註請放最後面 違者新聞文章刪除
1.媒體來源: AP News
2.記者署名:LAURAN NEERGAARD
3.完整新聞標題:Pfizer says 3 COVID shots protect children under 5
4.完整新聞內文:
Three doses of Pfizer’s COVID-19 vaccine offer strong protection for
children younger than 5, the company announced Monday. Pfizer plans to give
the data to U.S. regulators later this week in a step toward letting the
littlest kids get the shots.
輝瑞公司於週一宣布 三劑COVID-19疫苗能有效保護五歲以下的兒童 並計畫於本週
提交資料給美國監管機構
The news comes after months of anxious waiting by parents desperate to
vaccinate their babies, toddlers and preschoolers, especially as COVID-19
cases once again are rising. The 18 million tots under 5 are the only group
in the U.S. not yet eligible for COVID-19 vaccination.
The Food and Drug Administration has begun evaluating data from rival
Moderna, which hopes to begin offering two kid-sized shots by summer.
Pfizer has had a bumpier time figuring out its approach. It aims to give tots
an even lower dose — just one-tenth of the amount adults receive — but
discovered during its trial that two shots didn’t seem quite strong enough
for preschoolers. So researchers gave a third shot to more than 1,600
youngsters — from age 6 months to 4 years — during the winter surge of the
omicron variant.
In a press release, Pfizer and its partner BioNTech said the extra shot did
the trick, revving up tots’ levels of virus-fighting antibodies enough to
meet FDA criteria for emergency use of the vaccine with no safety problems.
Preliminary data suggested the three-dose series is 80% effective in
preventing symptomatic COVID-19, the companies said, but they cautioned the
calculation is based on just 10 cases diagnosed among study participants by
the end of April. The study rules state that at least 21 cases are needed to
formally determine effectiveness, and Pfizer promised an update as soon as
more data is available.
The companies already had submitted data on the first two doses to the FDA,
and BioNTech’s CEO, Dr. Ugur Sahin, said the final third-shot data would be
submitted this week.
“The study suggests that a low, 3-microgram dose of our vaccine, carefully
selected based on tolerability data, provides young children with a high
level of protection against the recent COVID-19 strains,” he said in a
statement.
What’s next? FDA vaccine chief Dr. Peter Marks has pledged the agency will “
move quickly without sacrificing our standards” in evaluating tot-sized
doses from both Pfizer and Moderna.
The agency has set tentative dates next month for its scientific advisers to
publicly debate data from each company.
Moderna is seeking to be the first to vaccinate the littlest kids. It
submitted data to the FDA saying tots develop high levels of virus-fighting
antibodies after two shots that contain a quarter of the dose given to
adults. The Moderna study found effectiveness against symptomatic COVID-19
was 40% to 50% during the omicon surge, much like for adults who’ve only had
two vaccine doses.
Complicating Moderna’s progress, the FDA so far has allowed its vaccine to
be used only in adults.
The FDA is expected to review Moderna’s data on both the youngest age group,
plus its study of teens and elementary-age children. Other countries already
have expanded Moderna’s shot to kids as young as 6.
While COVID-19 generally isn’t as dangerous to youngsters as to adults, some
children do become severely ill or even die. And the omicron variant hit
children especially hard, with those under 5 hospitalized at higher rates
than at the peak of the previous delta surge.
雖然COVID-19對青少年的危險性一般不比成人高 但有些兒童確實會得重病 甚至死亡
omicron變異對兒童的打擊特別大 5歲以下兒童的住院率比之前delta激增的高峰期還
要高
It’s not clear how much demand there will be to vaccinate the youngest kids.
Pfizer shots for 5- to 11-year-olds opened in November, but only about 30% of
that age group have gotten the recommended initial two doses. Last week, U.S.
health authorities said elementary-age children should get a booster shot
just like everyone 12 and older is supposed to get, for the best protection
against the latest coronavirus variants.
5.完整新聞連結 (或短網址)需放媒體原始連結，不可用轉載媒體連結:
https://bit.ly/3wBmf4w
6.備註:
--
給酷~ 給酷~ 給..給酷 給酷 給....啊!!!! 為什麼...為什麼不幫我發大絕極靈~~~~~ (斗
內:果然牛逼反觀斗基督機大神) 啊!!墮!! 啊!!! Double kill!! 巨槌瑞斯 誇爪~~ 哈哈
哈~哈哈哈哈!! 恩ㄣㄣㄣㄣ(轉手 哇!～還敢下來R冰鳥～～ 哇!老爸墮起來~Double kill~
哈哈哈~哈哈哈哈哈哈!! 哇! 哇~嬰兒! 哇! Double kill! 達瑞斯~~~ LALALALALALALALALA
~LALALALA!!!不要不要不要不要不要不要... 有囉！這波有囉~ 哈薩KI!吹起來!聊天室滑起
來!滑起來!!! Death is like the wind always by my side亞索開滑~~ WooWooWooWoo賀賀
--
※ 批踢踢實業坊(ptt.cc), 來自: 124.218.214.245 (臺灣)※ 文章網址: https://www.ptt.cc/bbs/Gossiping/M.1653304175.A.63D.html
推 soulivee: 信輝瑞得心肌炎220.129.224.136 05/23 19:11
→ takechance: 等美國EUA過了再吹 114.43.165.161 05/23 19:11
→ Kennyq: 怎麼黑bnt都沒用啦！看基隆前幾天打就知道 1.161.137.120 05/23 19:12
推 s655131: 太賺了 反正沒效或死人也不用負責 42.75.231.26 05/23 19:12
→ Kennyq: 幾百個都打bnt，莫德納跟高端跟AZ不到100 1.161.137.120 05/23 19:12
→ Kennyq: 沒效或死人也不用負責,你在說沒三期高端嗎 1.161.137.120 05/23 19:13
推 i376ers: 希望嬰幼兒能有合格的疫苗能打 114.24.78.243 05/23 19:13
推 Kennyq: 文章代碼(AID): #1YYAwgxA (Gossiping) 1.161.137.120 05/23 19:15
→ Kennyq: BNT474人，莫德納99人，AZ 2人，高端16人 1.161.137.120 05/23 19:16
推 jennyshe: 就是搶不到bnt, 114.36.79.44 05/23 19:18
推 siloin: 別小看台灣父母給小孩打3劑的決心 49.216.32.3 05/23 19:19
推 ks454: BNT可以趕快買一買嗎，家長很難作為欸 1.174.118.120 05/23 19:20
推 taot917: 請給我黃金 123.192.221.14 05/23 19:22
推 yesonline: 重點→ 80% effective against 220.133.253.85 05/23 19:22
→ fordmvp: 在18歲以上，莫德納比bnt 受歡迎。兒童 114.35.0.131 05/23 19:24
→ fordmvp: 目前也還看不出來誰比較受歡迎。兒童莫德 114.35.0.131 05/23 19:25
→ fordmvp: 納半劑目前為止也沒有聽說過有什麼嚴重 114.35.0.131 05/23 19:25
→ fordmvp: 副作用的啊！ 114.35.0.131 05/23 19:25
→ siloin: 我記得的就3例了，新聞不會這麼不識相啦 49.216.32.3 05/23 19:31
→ siloin: 現在是宣傳期 49.216.32.3 05/23 19:31
→ purplebfly: 要打3劑才有哦..你怎麼不去搶銀行算了 118.160.139.46 05/23 19:40
→ Lintw: 要買要快，到時候又搶不到了 111.82.170.183 05/23 19:50
噓 perasa: 輝瑞又在喇叭嘴了，一直唬爛就好了... 36.235.88.114 05/23 20:33
推 edison901: 唬爛的不到處都是？ 101.9.45.103 05/23 21:03
→ zhe23129: 反人類223.137.130.154 05/24 03:11
→ answertw: 一劑兩劑三劑 要不看看流感疫苗3劑 71.232.17.176 05/24 09:59
→ answertw: 有沒有效 71.232.17.176 05/24 09:59